Australia - engelsk - Department of Health (Therapeutic Goods Administration)

teva pharma australia pty ltd - lipegfilgrastim, quantity: 6 mg - injection, solution - excipient ingredients: acetic acid; polysorbate 20; sorbitol; sodium hydroxide; water for injections - lonquex? is indicated for reduction in the duration of neutropenia and the incidence of febrile neutropenia in adult patients treated with cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes)

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

amgen australia pty ltd - pegfilgrastim, quantity: 6 mg - injection, solution - excipient ingredients: sodium; polysorbate 20; acetate; sorbitol; water for injections - for the treatment of cancer patients following chemotherapy, to decrease the duration of severe neutropenia and so reduce the incidence of infection, as manifested by febrile neutropenia.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

amgen australia pty ltd - pegfilgrastim, quantity: 6 mg - injection, solution - excipient ingredients: sodium; polysorbate 20; acetate; sorbitol; water for injections - for the treatment of cancer patients following chemotherapy, to decrease the duration of severe neutropenia and so reduce the incidence of infection, as manifested by febrile neutropenia.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

amgen australia pty ltd - pegfilgrastim, quantity: 6 mg - injection, solution - excipient ingredients: sodium; polysorbate 20; acetate; sorbitol; water for injections - for the treatment of cancer patients following chemotherapy, to decrease the duration of severe neutropenia and so reduce the incidence of infection, as manifested by febrile neutropenia.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - pegfilgrastim, quantity: 6 mg - injection, solution - excipient ingredients: polysorbate 20; acetic acid; sodium hydroxide; water for injections; sorbitol - for the treatment of cancer patients following chemotherapy, to decrease the duration of severe neutropenia and so reduce the incidence of infection, as manifested by febrile neutropenia.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

maxx pharma pty ltd - pegfilgrastim, quantity: 6 mg - injection, solution - excipient ingredients: sorbitol; sodium; water for injections; polysorbate 20; acetate - fulphila is indicated for the treatment of cancer patients following chemotherapy, to decrease the duration of severe neutropenia and so reduce the incidence of infections, as manifested by febrile neutropenia.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

amgen australia pty ltd - pegfilgrastim, quantity: 6 mg - injection, solution - excipient ingredients: sodium; water for injections; sorbitol; polysorbate 20; acetate - for the treatment of cancer patients following chemotherapy to decrease the duration of severe neutropenia, and so reduce the incidence of infection, as manifested by febrile neutropenia.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - pegfilgrastim, quantity: 6 mg - injection, solution - excipient ingredients: water for injections; polysorbate 20; sorbitol; glacial acetic acid; sodium hydroxide - for the treatment of cancer patients following chemotherapy, to decrease the duration of severe neutropenia and so reduce the incidence of infection, as manifested by febrile neutropenia.

Israel - engelsk - Ministry of Health

kamada ltd, israel - pegfilgrastim - solution for injection - pegfilgrastim 10 mg/ml - pegfilgrastim - reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with cytotoxic chemotherapy, given at intervals of 14 days or more, for malignancy (with the exception of chronic myeloid leukemia and myelodysplastic syndromes).

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - pegfilgrastim, quantity: 6 mg - injection, solution - excipient ingredients: glacial acetic acid; polysorbate 20; sodium hydroxide; sorbitol; water for injections - for the treatment of cancer patients following chemotherapy, to decrease the duration of severe neutropenia and so reduce the incidence of infection, as manifested by febrile neutropenia.